CGON vs REGN: Which Stock is Better?
Side-by-side comparison of Cg Oncology Inc and Regeneron Pharmaceuticals Inc in 2026
CGON
Cg Oncology Inc
$73.43
REGN
Regeneron Pharmaceuticals Inc
$750.57
Key Metrics Comparison
| Metric | CGON | REGN | Winner |
|---|---|---|---|
| Market Cap | $6.20B | $79.35B | REGN |
| P/E Ratio | N/A | 18.08 | REGN |
| EPS (TTM) | $N/A | $41.51 | REGN |
| Revenue Growth | 4.1% | 0.0% | CGON |
| Gross Margin | -2902.2% | 44.6% | REGN |
Analyze CGON
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGON or REGN a better investment?
Comparing CGON and REGN: Cg Oncology Inc has a market cap of $6.20B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGON and REGN?
CGON (Cg Oncology Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGON or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGON or REGN?
CGON has higher revenue growth at 4.1% vs 0.0% for REGN.
Which company is more profitable: CGON or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to -2902.2% for CGON.
Which is the larger company: CGON or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $6.20B for CGON.
Should I buy CGON or REGN in 2026?
Both CGON and REGN have investment merit. CGON trades at $73.43 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGON and REGN stock?
Key differences: Market Cap ($6.20B vs $79.35B), P/E Ratio (N/A vs 18.1x), Revenue Growth (4.1% vs 0.0%), Gross Margin (-2902.2% vs 44.6%).